180 related articles for article (PubMed ID: 20570728)
1. Survival advantage of AMPK activation to androgen-independent prostate cancer cells during energy stress.
Chhipa RR; Wu Y; Mohler JL; Ip C
Cell Signal; 2010 Oct; 22(10):1554-61. PubMed ID: 20570728
[TBL] [Abstract][Full Text] [Related]
2. AMPK-mediated autophagy is a survival mechanism in androgen-dependent prostate cancer cells subjected to androgen deprivation and hypoxia.
Chhipa RR; Wu Y; Ip C
Cell Signal; 2011 Sep; 23(9):1466-72. PubMed ID: 21554950
[TBL] [Abstract][Full Text] [Related]
3. Androgens regulate prostate cancer cell growth via an AMPK-PGC-1α-mediated metabolic switch.
Tennakoon JB; Shi Y; Han JJ; Tsouko E; White MA; Burns AR; Zhang A; Xia X; Ilkayeva OR; Xin L; Ittmann MM; Rick FG; Schally AV; Frigo DE
Oncogene; 2014 Nov; 33(45):5251-61. PubMed ID: 24186207
[TBL] [Abstract][Full Text] [Related]
4. Activation of AMP-activated protein kinase by 3,3'-Diindolylmethane (DIM) is associated with human prostate cancer cell death in vitro and in vivo.
Chen D; Banerjee S; Cui QC; Kong D; Sarkar FH; Dou QP
PLoS One; 2012; 7(10):e47186. PubMed ID: 23056607
[TBL] [Abstract][Full Text] [Related]
5. Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-Troglitazone-induced Apoptosis in Prostate Cancer Cells Involve AMP-activated Protein Kinase.
Santha S; Viswakarma N; Das S; Rana A; Rana B
J Biol Chem; 2015 Sep; 290(36):21865-75. PubMed ID: 26198640
[TBL] [Abstract][Full Text] [Related]
6. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI
Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644
[TBL] [Abstract][Full Text] [Related]
7. CaM kinase kinase beta-mediated activation of the growth regulatory kinase AMPK is required for androgen-dependent migration of prostate cancer cells.
Frigo DE; Howe MK; Wittmann BM; Brunner AM; Cushman I; Wang Q; Brown M; Means AR; McDonnell DP
Cancer Res; 2011 Jan; 71(2):528-37. PubMed ID: 21098087
[TBL] [Abstract][Full Text] [Related]
8. AMP-activated protein kinase promotes human prostate cancer cell growth and survival.
Park HU; Suy S; Danner M; Dailey V; Zhang Y; Li H; Hyduke DR; Collins BT; Gagnon G; Kallakury B; Kumar D; Brown ML; Fornace A; Dritschilo A; Collins SP
Mol Cancer Ther; 2009 Apr; 8(4):733-41. PubMed ID: 19372545
[TBL] [Abstract][Full Text] [Related]
9. C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP.
Engedal N; Korkmaz CG; Saatcioglu F
Oncogene; 2002 Feb; 21(7):1017-27. PubMed ID: 11850819
[TBL] [Abstract][Full Text] [Related]
10. GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling.
White MA; Tsouko E; Lin C; Rajapakshe K; Spencer JM; Wilkenfeld SR; Vakili SS; Pulliam TL; Awad D; Nikolos F; Katreddy RR; Kaipparettu BA; Sreekumar A; Zhang X; Cheung E; Coarfa C; Frigo DE
Endocr Relat Cancer; 2018 Apr; 25(4):453-469. PubMed ID: 29431615
[TBL] [Abstract][Full Text] [Related]
11. CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells.
Roca H; Varsos ZS; Pienta KJ
Neoplasia; 2009 Dec; 11(12):1309-17. PubMed ID: 20019839
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of AMPK alters gene expression and promotes growth of prostate cancer cells.
Zhou J; Huang W; Tao R; Ibaragi S; Lan F; Ido Y; Wu X; Alekseyev YO; Lenburg ME; Hu GF; Luo Z
Oncogene; 2009 May; 28(18):1993-2002. PubMed ID: 19347029
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of IGFBP-3 by the androgen receptor in the lineage-related androgen-dependent LNCaP and androgen-independent C4-2 prostate cancer models.
Kojima S; Mulholland DJ; Ettinger S; Fazli L; Nelson CC; Gleave ME
Prostate; 2006 Jun; 66(9):971-86. PubMed ID: 16541420
[TBL] [Abstract][Full Text] [Related]
14. Induction of FLIP expression by androgens protects prostate cancer cells from TRAIL-mediated apoptosis.
Raclaw KA; Heemers HV; Kidd EM; Dehm SM; Tindall DJ
Prostate; 2008 Nov; 68(15):1696-706. PubMed ID: 18726983
[TBL] [Abstract][Full Text] [Related]
15. Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer: a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation.
Chang WL; Hsu LC; Leu WJ; Chen CS; Guh JH
Oncotarget; 2015 Nov; 6(37):39806-20. PubMed ID: 26447757
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence.
Ettinger SL; Sobel R; Whitmore TG; Akbari M; Bradley DR; Gleave ME; Nelson CC
Cancer Res; 2004 Mar; 64(6):2212-21. PubMed ID: 15026365
[TBL] [Abstract][Full Text] [Related]
17. Requirement of androgen-dependent activation of protein kinase Czeta for androgen-dependent cell proliferation in LNCaP Cells and its roles in transition to androgen-independent cells.
Inoue T; Yoshida T; Shimizu Y; Kobayashi T; Yamasaki T; Toda Y; Segawa T; Kamoto T; Nakamura E; Ogawa O
Mol Endocrinol; 2006 Dec; 20(12):3053-69. PubMed ID: 16931574
[TBL] [Abstract][Full Text] [Related]
18. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
19. The radiation response of androgen-refractory prostate cancer cell line C4-2 derived from androgen-sensitive cell line LNCaP.
Xie BX; Zhang H; Yu L; Wang J; Pang B; Wu RQ; Qian XL; Li SH; Shi QG; Wang LL; Zhou JG
Asian J Androl; 2010 May; 12(3):405-14. PubMed ID: 20118949
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway.
Miyake H; Nelson C; Rennie PS; Gleave ME
Endocrinology; 2000 Jun; 141(6):2257-65. PubMed ID: 10830316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
